Which has the lower trailing P/E, MA or MEDP?

MA has the lower trailing P/E: MA trades at 31.31 and MEDP at 34.42. P/E is one valuation measure and does not by itself establish which business is cheaper.

Which has grown faster, MA or MEDP?

Over the past five years, MEDP grew revenue faster — MA at a 16.09% CAGR versus MEDP at 22.03%.

Does MA or MEDP pay a bigger dividend?

MA pays a dividend (0.60% yield), while MEDP has no payments in the available dividend history.

Is MA or MEDP more profitable?

MA runs the higher net margin — MA at 46.34% versus MEDP at 17.67%.

How have MA and MEDP total returns compared?

Over the past 10 years, MA delivered 19.83% and MEDP delivered 34.74% annualized total return. Past performance doesn't predict future results.

Mastercard Incorporated (MA) vs Medpace Holdings, Inc. (MEDP)

A side-by-side comparison of Mastercard Incorporated and Medpace Holdings, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of September 11, 2026. Differences are shown without an overall score or investment verdict.

Different business models: MA is classified in Financial Services; MEDP is classified in Healthcare. Margin, capital intensity, and valuation differences should be interpreted in that sector context.

Mastercard Incorporated

$499.20B

$569.19Financial ServicesDelayed quote: Sep 11, 2026, 4:00 PM EDT

MEDP

Medpace Holdings, Inc.

$16.40B

$587.52HealthcareDelayed quote: Sep 11, 2026, 4:00 PM EDT

Total return — MA vs MEDP

growth of $100 · dividends reinvested · last 10y

MA +498.8% (+19.6%/yr)MEDP +1860.2% (+34.7%/yr)MEDP compounded faster over this window

MA MEDP

MA vs MEDP: by the numbers

•MA is the larger company ($499.20B vs $16.40B market cap).
•MA trades at the lower trailing earnings multiple (31.31 vs 34.42 P/E), one valuation lens rather than an overall verdict.
•MA converts more revenue to profit (46.34% vs 17.67% net margin).
•MEDP grew revenue faster over the past five years (22.03% vs 16.09% CAGR).
•MA pays a dividend (0.60% yield), while MEDP has no payments in the available dividend history.

Metrics side by side

Valuation

Metric	MA	MEDP
P/E ratio	31.31	34.42
Forward P/E	28.52	33.38
P/S ratio	14.23	5.89
P/B ratio	88.97	37.80
EV / EBITDA	N/A	26.20
FCF yield	N/A	4.28%

Profitability

Metric	MA	MEDP
Gross margin	100.00%	28.76%
Operating margin	59.84%	20.97%
Net margin	46.34%	17.67%
ROE	289.73%	113.29%
ROIC	N/A	77.00%

Dividends

Metric	MA	MEDP
Dividend yield	0.60%	N/A
Payout ratio	18.54%	N/A

Growth (annualized)

Metric	MA	MEDP
Revenue CAGR (5Y)	16.09%	22.03%
EPS CAGR (5Y)	20.93%	30.90%
FCF CAGR (5Y)	N/A	23.40%
Total return CAGR (5Y)	10.88%	24.92%

Frequently asked

Which has the lower trailing P/E, MA or MEDP?: MA has the lower trailing P/E: MA trades at 31.31 and MEDP at 34.42. P/E is one valuation measure and does not by itself establish which business is cheaper.
Which has grown faster, MA or MEDP?: Over the past five years, MEDP grew revenue faster — MA at a 16.09% CAGR versus MEDP at 22.03%.
Does MA or MEDP pay a bigger dividend?: MA pays a dividend (0.60% yield), while MEDP has no payments in the available dividend history.
Is MA or MEDP more profitable?: MA runs the higher net margin — MA at 46.34% versus MEDP at 17.67%.
How have MA and MEDP total returns compared?: Over the past 10 years, MA delivered 19.83% and MEDP delivered 34.74% annualized total return. Past performance doesn't predict future results.

Go deeper

Full MA analysis Full MEDP analysis Interactive comparison tool

Dig into the metrics

Mastercard P/E ratio Medpace P/E ratio Mastercard dividend yield Mastercard ROE Medpace ROE Mastercard operating margin Medpace operating margin Mastercard revenue growth Medpace revenue growth Medpace free cash flow

Mastercard & Medpace appear in these rankings

Fastest Revenue Growth Stocks Highest ROE Stocks Highest ROIC Stocks Highest Operating Margin Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified September 11, 2026.